132 related articles for article (PubMed ID: 38549387)
21. Oral Tongue Cancer in a Patient with Fanconi Anemia: A Case Report and Literature Review.
Deng S; Ye W; Zhang S; Zhu G; Zhang P; Song Y; Duan F; Lang J; Lu S
Cancer Manag Res; 2021; 13():3145-3154. PubMed ID: 33883933
[TBL] [Abstract][Full Text] [Related]
22. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
[TBL] [Abstract][Full Text] [Related]
23. Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature.
Beckham TH; Leeman J; Jillian Tsai C; Riaz N; Sherman E; Singh B; Lee N; McBride S; Higginson DS
Head Neck; 2019 May; 41(5):1418-1426. PubMed ID: 30633423
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity.
Ristau J; Thiel M; Katayama S; Schlampp I; Lang K; Häfner MF; Herfarth K; Debus J; Koerber SA
Radiat Oncol; 2021 Feb; 16(1):23. PubMed ID: 33522923
[TBL] [Abstract][Full Text] [Related]
25. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
26. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
[TBL] [Abstract][Full Text] [Related]
27. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
28. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: preliminary results of phase II trial.
Hainsworth JD; Meluch AA; Greco FA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-38-S19-42. PubMed ID: 9427264
[TBL] [Abstract][Full Text] [Related]
30. Three Cases of Esophageal Cancer Related to Fanconi Anemia.
Fujisawa M; Matsushima M; Ueda T; Kaneko M; Fujimoto R; Sano M; Teramura E; Monma M; Mizukami H; Nakahara F; Suzuki H; Suzuki T; Yabe M; Yabe T
Intern Med; 2021 Sep; 60(18):2953-2959. PubMed ID: 33814498
[TBL] [Abstract][Full Text] [Related]
31. Postoperative clinical radiosensitivity in patients with fanconi anemia and head and neck squamous cell carcinoma.
Birkeland AC; Auerbach AD; Sanborn E; Parashar B; Kuhel WI; Chandrasekharappa SC; Smogorzewska A; Kutler DI
Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):930-4. PubMed ID: 21930984
[TBL] [Abstract][Full Text] [Related]
32. Higher Doses of Neoadjuvant Radiation for Esophageal Cancer Do Not Affect the Pathologic Complete Response Rate or Survival: A Propensity-Matched Analysis.
Worrell SG; Towe CW; A Dorth J; Machtay M; Perry Y; Linden PA
Ann Surg Oncol; 2020 Feb; 27(2):500-508. PubMed ID: 31571054
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes.
Lee RH; Kang H; Yom SS; Smogorzewska A; Johnson DE; Grandis JR
Clin Cancer Res; 2021 Oct; 27(19):5168-5187. PubMed ID: 34045293
[TBL] [Abstract][Full Text] [Related]
34. Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma.
Lee HJ; Zelefsky MJ; Kraus DH; Pfister DG; Strong EW; Raben A; Shah JP; Harrison LB
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):995-1000. PubMed ID: 9276364
[TBL] [Abstract][Full Text] [Related]
35. Esophageal extraskeletal neoplasm Ewing's sarcoma: Case report.
Khalid H; Hussain N; Shamshad R
Int J Surg Case Rep; 2022 Aug; 97():107399. PubMed ID: 35926382
[TBL] [Abstract][Full Text] [Related]
36. Tongue surface model can predict radiation tongue mucositis due to intensity-modulated radiation therapy for head and neck cancer.
Musha A; Fukata K; Saitoh JI; Shirai K; Abe T; Mizukami T; Kawashima M; Yokoo S; Chikamatsu K; Ohno T; Nakano T
Int J Oral Maxillofac Surg; 2020 Jan; 49(1):44-50. PubMed ID: 31248705
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature.
Delishaj D; Fumagalli IC; Ursino S; Cristaudo A; Colangelo F; Stefanelli A; Alghisi A; De Nobili G; D'Amico R; Cocchi A; Ardizzoia A; Soatti CP
World J Clin Cases; 2021 Oct; 9(30):9077-9089. PubMed ID: 34786390
[TBL] [Abstract][Full Text] [Related]
38. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
[TBL] [Abstract][Full Text] [Related]
39. Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy.
Kim JW; Kim TH; Kim JH; Lee IJ
World J Gastroenterol; 2018 Feb; 24(7):862-869. PubMed ID: 29467556
[TBL] [Abstract][Full Text] [Related]
40. Decreased radiation doses to tongue with "stick-out" tongue position over neutral tongue position in head and neck cancer patients who refused or could not tolerate an intraoral device (bite-block, tongue blade, or mouthpiece) due to trismus, gag reflex, or discomfort during intensity-modulated radiation therapy.
Kil WJ; Kulasekere C; Derrwaldt R; Bugno J; Hatch C
Oncotarget; 2016 Aug; 7(33):53029-53036. PubMed ID: 27447973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
